A new analysis shows the patented Ginkgo biloba extract, EGb 761, to effectively improve the mental function of Alzheimer's disease and dementia patients within the first 26 weeks of treatment.
In a double blind, placebo controlled study, changes in the cognitive function, daily living and social behavior of 309 patients were evaluated. While study participants receiving 120 mg per day of the patented EGb761 extract exhibited clinically relevant improvement, the placebo group showed significant worsening in two areas of assessment.
Regarding safety, no differences between the two groups were observed. Specifically, 26% of the patients in the Ginkgo group achieved at least a 4-point improvement one score and 30% improved on another measure of cognitive function. The Gingko extract Egb 761 is sold as Ginkoba (Pharmaton), Ginkgold (Nature's Way) and Quanterra Mental Sharpness (Warner-Lambert).
All research on this web site is the property of Leslie Beck Nutrition Consulting Inc. and is protected by copyright. Keep in mind that research on these matters continues daily and is subject to change. The information presented is not intended as a substitute for medical treatment. It is intended to provide ongoing support of your healthy lifestyle practices.